Nanotechnology Synergised Immunoengineering for Cancer.

[1]  Jianmin Ye,et al.  Interleukin-10 (IL-10) participates in host defense against bacterial pathogens and promotes IgM antibody production in Nile tilapia (Oreochromis niloticus) , 2021 .

[2]  T. Daemen,et al.  Therapeutic Vaccines and Cancer Immunotherapy , 2020, Vaccines.

[3]  C. Contag,et al.  Nano-immunoimaging. , 2020, Nanoscale Horizons.

[4]  Dongpei Li,et al.  Cancer immunotherapy: Pros, cons and beyond. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  A. Ranjan,et al.  Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. , 2019, Pharmacology & therapeutics.

[6]  A. Phan,et al.  Immunotherapy and targeted therapy-the new roadmap in cancer treatment. , 2019, Annals of translational medicine.

[7]  K. O'Byrne,et al.  Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis , 2019, Annals of Oncology.

[8]  Pei-Wei Huang,et al.  Immune checkpoint inhibitors win the 2018 Nobel Prize , 2019, Biomedical journal.

[9]  Kyung Soo Park,et al.  Engineering patient-specific cancer immunotherapies , 2019, Nature Biomedical Engineering.

[10]  A. De,et al.  Comprehensive Evaluation of Degradable and Cost-Effective Plasmonic Nanoshells for Localized Photothermolysis of Cancer Cells. , 2019, Langmuir : the ACS journal of surfaces and colloids.

[11]  Jianying Zhou,et al.  Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial , 2019, The Lancet.

[12]  M. Szewczuk,et al.  Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates , 2019, Journal of oncology.

[13]  Tan Tang,et al.  Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications. , 2019, Biomaterials science.

[14]  Rachel S. Riley,et al.  Delivery technologies for cancer immunotherapy , 2019, Nature Reviews Drug Discovery.

[15]  F. Kiessling,et al.  Nanomedicine and macroscale materials in immuno-oncology. , 2019, Chemical Society reviews.

[16]  Lingyu Wang,et al.  The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review , 2019, Technology in cancer research & treatment.

[17]  Miles A. Miller,et al.  Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin. , 2018, ACS nano.

[18]  S. M. Toor,et al.  Immune checkpoint inhibitors: recent progress and potential biomarkers , 2018, Experimental & Molecular Medicine.

[19]  A. De,et al.  Enhanced EPR directed and Imaging guided Photothermal Therapy using Vitamin E Modified Toco-Photoxil , 2018, Scientific Reports.

[20]  E. Winer,et al.  Atezolizumab and Nab‐Paclitaxel in Advanced Triple‐Negative Breast Cancer , 2018, The New England journal of medicine.

[21]  Tyler J. Reich,et al.  Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell , 2018, Nature Medicine.

[22]  Leaf Huang,et al.  Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers. , 2018, ACS nano.

[23]  A. Tafreshi,et al.  Pembrolizumab plus Chemotherapy for Squamous Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[24]  Beiyan Zhou,et al.  Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses , 2018, Expert opinion on biological therapy.

[25]  Yuliang Zhao,et al.  Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization , 2018, Advanced materials.

[26]  Chenfeng Xu,et al.  Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy. , 2018, Molecular pharmaceutics.

[27]  S. Gambhir,et al.  Ferumoxytol-based Dual-modality Imaging Probe for Detection of Stem Cell Transplant Rejection , 2018, Nanotheranostics.

[28]  Yanfeng Luo,et al.  Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration , 2018 .

[29]  Yaping Li,et al.  A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors , 2018, Nature Communications.

[30]  Michael F. Cuccarese,et al.  TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy , 2018, Nature Biomedical Engineering.

[31]  S. Novello,et al.  Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[32]  Angela E. Leek,et al.  Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies , 2018, Cancer cell.

[33]  N. Bercovici,et al.  Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment , 2018, Proceedings of the National Academy of Sciences.

[34]  N. Steinmetz,et al.  Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression , 2018, ACS omega.

[35]  S. Son,et al.  Elimination of established tumors with nanodisc-based combination chemoimmunotherapy , 2018, Science Advances.

[36]  S. Son,et al.  Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer , 2018, Nature Communications.

[37]  Christopher A. Lazarski,et al.  A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy , 2018, Cell Research.

[38]  Zhuang Liu,et al.  In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy , 2018, Science Translational Medicine.

[39]  D. Zheng,et al.  Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication. , 2018, ACS nano.

[40]  Chunshui Yu,et al.  Antigen‐Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal‐Immunotherapy , 2018, Advanced materials.

[41]  K. Davis,et al.  Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia , 2018, The New England journal of medicine.

[42]  Aileen W. Li,et al.  A facile approach to enhance antigen response for personalized cancer vaccination , 2018, Nature Materials.

[43]  J. Bamber,et al.  Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment , 2018, International journal of cancer.

[44]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[45]  Matthew D. Hellmann,et al.  Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade , 2018, The New England journal of medicine.

[46]  A. Rogel,et al.  The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. , 2018, Blood.

[47]  I. Melero,et al.  Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies. , 2018, Blood.

[48]  Yuhua Wang,et al.  Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  D. Irvine,et al.  Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity , 2018, Nature Communications.

[50]  Li Yang,et al.  An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy , 2018, Theranostics.

[51]  Stephen J. Schuster,et al.  Chimeric Antigen Receptor T Cells in Refractory B‐Cell Lymphomas , 2017, The New England journal of medicine.

[52]  R. Levy,et al.  Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma , 2017, The New England journal of medicine.

[53]  Ping Liu,et al.  Platelet-inspired medicine for tumor therapy , 2017, Oncotarget.

[54]  W. Gillanders,et al.  Preclinical and clinical development of neoantigen vaccines. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  M. Ringnér,et al.  Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.

[56]  D. Irvine,et al.  Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy. , 2017, Nano letters.

[57]  G. Linette,et al.  CAR T-Cell Therapies in Glioblastoma: A First Look , 2017, Clinical Cancer Research.

[58]  Derek W. Yecies,et al.  Wide-field dynamic monitoring of immune cell trafficking in murine models of glioblastoma , 2017, bioRxiv.

[59]  J. Hubbell,et al.  Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events , 2017, Science Translational Medicine.

[60]  Gordon J. Freeman,et al.  T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity , 2017, Nature Communications.

[61]  Tomoki Shiomi,et al.  DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy. , 2017, Biomaterials.

[62]  Nikhil Wagle,et al.  Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.

[63]  H. Ghaznavi,et al.  Folic acid conjugated PEG coated gold–iron oxide core–shell nanocomplex as a potential agent for targeted photothermal therapy of cancer , 2017, Artificial cells, nanomedicine, and biotechnology.

[64]  Fan Wang,et al.  Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes. , 2017, ACS nano.

[65]  Lisa Rosenbaum.  Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy. , 2017, The New England journal of medicine.

[66]  Zhiping Zhang,et al.  Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy. , 2017, Nano letters.

[67]  Y. Ung,et al.  Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review. , 2017, Clinical lung cancer.

[68]  C. Figdor,et al.  Synthetic immune niches for cancer immunotherapy , 2017, Nature Reviews Immunology.

[69]  A. Iyer,et al.  PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome , 2017, Front. Pharmacol..

[70]  G. Palmer,et al.  Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers , 2017, Scientific Reports.

[71]  I. Durán,et al.  Biomarkers of response to PD-1/PD-L1 inhibition. , 2017, Critical reviews in oncology/hematology.

[72]  P. Agostinis,et al.  Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape. , 2017, Trends in immunology.

[73]  Zhiping Zhang,et al.  Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency , 2017, Theranostics.

[74]  K. Mansfield,et al.  A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma , 2017, Science Translational Medicine.

[75]  J. Utikal,et al.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.

[76]  Charles H. Yoon,et al.  An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.

[77]  H. Imahori,et al.  Surface chemistry for cytosolic gene delivery and photothermal transgene expression by gold nanorods , 2017, Scientific Reports.

[78]  Rachel S. Riley,et al.  Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[79]  E. Schmidt,et al.  Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors , 2017, Clinical Cancer Research.

[80]  Ran Mo,et al.  Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. , 2017, Nature nanotechnology.

[81]  Joo Yeon Park,et al.  Nanoformulation‐based sequential combination cancer therapy☆ , 2017, Advanced drug delivery reviews.

[82]  Austin J. Moy,et al.  Combinatorial immunotherapy and nanoparticle mediated hyperthermia. , 2017, Advanced drug delivery reviews.

[83]  Miles A. Miller,et al.  In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy , 2017, Science Translational Medicine.

[84]  D. Irvine,et al.  Delivering safer immunotherapies for cancer , 2017, Advanced drug delivery reviews.

[85]  Zhuang Liu,et al.  Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer. , 2017, ACS nano.

[86]  Matthias T Stephan,et al.  In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. , 2017, Nature nanotechnology.

[87]  J. Wolchok,et al.  Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies , 2017, Nature Reviews Endocrinology.

[88]  L. Müller,et al.  Type I Interferons and Natural Killer Cell Regulation in Cancer , 2017, Front. Immunol..

[89]  Chen Li,et al.  A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy. , 2017, Molecular pharmaceutics.

[90]  J. Nemunaitis,et al.  Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer , 2017, Journal of Immunotherapy for Cancer.

[91]  K. Shen,et al.  Recent progress in GM-CSF-based cancer immunotherapy. , 2017, Immunotherapy.

[92]  Li Tang,et al.  Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors. , 2017, ACS nano.

[93]  C. Rudin,et al.  Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  S. Kawakami,et al.  Synthesis and Functional Characterization of Novel Sialyl LewisX Mimic-Decorated Liposomes for E-selectin-Mediated Targeting to Inflamed Endothelial Cells. , 2017, Molecular pharmaceutics.

[95]  W. Lim,et al.  The Principles of Engineering Immune Cells to Treat Cancer , 2017, Cell.

[96]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[97]  S. Rivella,et al.  Targeting iron metabolism in drug discovery and delivery , 2017, Nature Reviews Drug Discovery.

[98]  D. Teachey,et al.  Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia , 2017, Critical care medicine.

[99]  S. Gambhir,et al.  Nanomaterials for In Vivo Imaging. , 2017, Chemical reviews.

[100]  Bruce L. Levine,et al.  Global Manufacturing of CAR T Cell Therapy , 2016, Molecular therapy. Methods & clinical development.

[101]  R. Weichselbaum,et al.  Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. , 2016, Journal of the American Chemical Society.

[102]  In‐San Kim,et al.  Bioengineered protein-based nanocage for drug delivery. , 2016, Advanced drug delivery reviews.

[103]  J. Moon,et al.  Designer vaccine nanodiscs for personalized cancer immunotherapy , 2016, Nature materials.

[104]  M. Sadelain,et al.  Soluble and membrane‐bound interleukin (IL)‐15 Rα/IL‐15 complexes mediate proliferation of high‐avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections , 2016, Clinical and Experimental Immunology.

[105]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[106]  Daniel G. Anderson,et al.  Materials for non-viral intracellular delivery of messenger RNA therapeutics. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[107]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[108]  R. Levy,et al.  Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody , 2016, Clinical Cancer Research.

[109]  L. Zitvogel,et al.  Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.

[110]  Daniel G. Anderson,et al.  Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination , 2016, Proceedings of the National Academy of Sciences.

[111]  Zhen Gu,et al.  Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody , 2016, Advanced materials.

[112]  Asher Mullard.  The cancer vaccine resurgence , 2016, Nature Reviews Drug Discovery.

[113]  S. Gettinger,et al.  Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  P. Choyke,et al.  Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy , 2016, Science Translational Medicine.

[115]  Ralph R. Weichselbaum,et al.  Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy , 2016, Nature Communications.

[116]  Zhaocai Zhou,et al.  Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy. , 2016, Nano letters.

[117]  Sarah E Bohndiek,et al.  Contrast agents for molecular photoacoustic imaging , 2016, Nature Methods.

[118]  J. Wolchok,et al.  Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient , 2016, The Journal of experimental medicine.

[119]  M. Hoehn,et al.  In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke , 2016, PloS one.

[120]  D. Cui,et al.  Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy , 2016, Nanoscale Research Letters.

[121]  Özlem Türeci,et al.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.

[122]  Andrea Sbarbati,et al.  Magnetic resonance imaging of ultrasmall superparamagnetic iron oxide-labeled exosomes from stem cells: a new method to obtain labeled exosomes , 2016, International journal of nanomedicine.

[123]  P. Chanson,et al.  Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[124]  Jing Zhao,et al.  Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma. , 2016, Journal of biomedical nanotechnology.

[125]  D. Munn,et al.  Immune suppressive mechanisms in the tumor microenvironment. , 2016, Current opinion in immunology.

[126]  Zhen Gu,et al.  Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. , 2016, Nano letters.

[127]  C. Murphy,et al.  Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles , 2016 .

[128]  J. Gartner,et al.  Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients , 2016, Nature Medicine.

[129]  Wei R. Chen,et al.  Photonics immunotherapy-A novel strategy for cancer treatment , 2016 .

[130]  A. Snyder,et al.  Acquired resistance to immunotherapy and future challenges , 2016, Nature Reviews Cancer.

[131]  David J. Mooney,et al.  Biomaterials and emerging anticancer therapeutics: engineering the microenvironment , 2015, Nature Reviews Cancer.

[132]  P. Lizotte,et al.  In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer , 2015, Nature nanotechnology.

[133]  S. Nair,et al.  RNA-Based Vaccines in Cancer Immunotherapy , 2015, Journal of immunology research.

[134]  P. B. van Driel,et al.  Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors , 2015, Clinical Cancer Research.

[135]  Yuhua Wang,et al.  Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma. , 2015, Biomaterials.

[136]  Sun‐Young Kim,et al.  Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy , 2015, International journal of nanomedicine.

[137]  W. Fong,et al.  Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model , 2015, Cellular and Molecular Immunology.

[138]  David L. Porter,et al.  Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia , 2015, Science Translational Medicine.

[139]  Bent K Jakobsen,et al.  Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[140]  David J Mooney,et al.  Injectable cryogel-based whole-cell cancer vaccines , 2015, Nature Communications.

[141]  R. McEver.  Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. , 2015, Cardiovascular research.

[142]  W. Hennink,et al.  Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer. , 2015, Biomaterials.

[143]  H. Byrne,et al.  Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi‐Peptide Nanoparticles to Tumor‐Associated Macrophages and Cancer Cells , 2015, Advanced functional materials.

[144]  Dong Wang,et al.  Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. , 2015, ACS nano.

[145]  S. Goldberg,et al.  Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy , 2015, PloS one.

[146]  Zhen Gu,et al.  Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery , 2015, Proceedings of the National Academy of Sciences.

[147]  Wenbin Lin,et al.  A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers. , 2015, Journal of the American Chemical Society.

[148]  Liangzhu Feng,et al.  Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy. , 2015, ACS nano.

[149]  Li Yang,et al.  Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking , 2015 .

[150]  Elizabeth A. Repasky,et al.  Fever and the thermal regulation of immunity: the immune system feels the heat , 2015, Nature Reviews Immunology.

[151]  M. Kortylewski,et al.  TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients , 2015, Clinical Cancer Research.

[152]  G. McArthur,et al.  Radiotherapy complements immune checkpoint blockade. , 2015, Cancer cell.

[153]  Yi Yan Yang,et al.  Ovarian Cancer Immunotherapy Using PD‐L1 siRNA Targeted Delivery from Folic Acid‐Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing , 2015, Advanced healthcare materials.

[154]  Wei R. Chen,et al.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. , 2015, Cancer letters.

[155]  P. Sharma,et al.  Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential , 2015, Cell.

[156]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[157]  Taeghwan Hyeon,et al.  Upconverting nanoparticles: a versatile platform for wide-field two-photon microscopy and multi-modal in vivo imaging. , 2015, Chemical Society reviews.

[158]  Dulce M Santos,et al.  Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein. , 2015, Molecular immunology.

[159]  Wei Zhang,et al.  Calreticulin as Cancer Treatment Adjuvant: Combination with Photodynamic Therapy and Photodynamic Therapy-Generated Vaccines , 2015, Front. Oncol..

[160]  S. H. van der Burg,et al.  CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. , 2015, Biomaterials.

[161]  J. Wolchok,et al.  Immune Checkpoint Blockade in Cancer Therapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[162]  Matthew J. Frigault,et al.  Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells , 2015, Cancer Immunology Research.

[163]  Youngjin Choi,et al.  Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy , 2014, Nature Biotechnology.

[164]  Ligeng Xu,et al.  Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti‐CTLA‐4 Therapy to Inhibit Cancer Metastasis , 2014, Advanced materials.

[165]  S. Fiering,et al.  Local tumour hyperthermia as immunotherapy for metastatic cancer , 2014, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[166]  S. B. Stephan,et al.  Biopolymer implants enhance the efficacy of adoptive T cell therapy , 2014, Nature Biotechnology.

[167]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[168]  P. Mishra,et al.  Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine. , 2014, Nanomedicine.

[169]  T. Wu,et al.  DNA vaccine for cancer immunotherapy , 2014, Human vaccines & immunotherapeutics.

[170]  C. Löwik,et al.  Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[171]  Y. Lim,et al.  Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy. , 2014, Biomaterials.

[172]  M. Fotin‐Mleczek,et al.  mRNA-based vaccines synergize with radiation therapy to eradicate established tumors , 2014, Radiation oncology.

[173]  X. Qu,et al.  Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy. , 2014, Biomaterials.

[174]  P Jack Hoopes,et al.  Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[175]  A. Sandler,et al.  Prussian blue nanoparticles for laser-induced photothermal therapy of tumors , 2014 .

[176]  David C. Zhu,et al.  CD44 Targeting Magnetic Glyconanoparticles for Atherosclerotic Plaque Imaging , 2014, Pharmaceutical Research.

[177]  C. Ge,et al.  Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation. , 2014, Oncology research.

[178]  M. De la Fuente,et al.  Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.

[179]  Wei Lu,et al.  Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles , 2014, ACS nano.

[180]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy. , 2014, Current opinion in immunology.

[181]  Ronnie H. Fang,et al.  Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.

[182]  David J Mooney,et al.  Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. , 2014, Cancer research.

[183]  David J Mooney,et al.  Injectable, porous, and cell-responsive gelatin cryogels. , 2014, Biomaterials.

[184]  Yuhua Wang,et al.  Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment , 2014, ACS nano.

[185]  M. Mansour,et al.  Therapeutic vaccines and cancer: focus on DPX-0907 , 2014, Biologics : targets & therapy.

[186]  R. Weichselbaum,et al.  Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. , 2014, The Journal of clinical investigation.

[187]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[188]  Gregory L. Szeto,et al.  Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.

[189]  Jennifer Couzin-Frankel,et al.  Breakthrough of the year 2013. Cancer immunotherapy. , 2013, Science.

[190]  G. Vanham,et al.  Challenges and advances towards the rational design of mRNA vaccines. , 2013, Trends in molecular medicine.

[191]  Lu Zhang,et al.  Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[192]  David J Mooney,et al.  Inflammatory Cytokines Presented from Polymer Matrices Differentially Generate and Activate DCs In Situ , 2013, Advanced functional materials.

[193]  J. Wolchok,et al.  Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma , 2013, The Journal of experimental medicine.

[194]  Adam Bagg,et al.  Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. , 2013, Blood.

[195]  Bent K Jakobsen,et al.  Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells , 2013, Science Translational Medicine.

[196]  R. Drezek,et al.  Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer , 2013, PloS one.

[197]  Darrell J Irvine,et al.  In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[198]  R. Germain,et al.  The future of immunoimaging — Deeper, bigger, more precise, and definitively more colorful , 2013, European journal of immunology.

[199]  R. Omary,et al.  MRI-Monitored Transcatheter Intra-Arterial Delivery of SPIO-Labeled Natural Killer Cells to Hepatocellular Carcinoma: Preclinical Studies in a Rodent Model , 2013, Investigative radiology.

[200]  M. Jit,et al.  A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls , 2013, PloS one.

[201]  C. Nathan,et al.  Beyond oxidative stress: an immunologist's guide to reactive oxygen species , 2013, Nature Reviews Immunology.

[202]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[203]  M. S. Singh,et al.  Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model. , 2013, International journal of pharmaceutics.

[204]  Guoqiang Yu,et al.  Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies , 2013, Lasers in Medical Science.

[205]  Di Chen,et al.  Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model , 2013, International journal of cancer.

[206]  C. Liu,et al.  Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion , 2013, Nature Medicine.

[207]  T. Schlake,et al.  Developing mRNA-vaccine technologies , 2012, RNA biology.

[208]  Richard A Flavell,et al.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. , 2012, Nature materials.

[209]  R. Kimmig,et al.  A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study. , 2012 .

[210]  Daejin Kim,et al.  Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. , 2012, Angewandte Chemie.

[211]  Zhen Cheng,et al.  The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles. , 2012, Biomaterials.

[212]  M. van den Broek,et al.  Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation , 2012, The Journal of Immunology.

[213]  Tuan Vo-Dinh,et al.  TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. , 2012, Journal of the American Chemical Society.

[214]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[215]  Eric Stern,et al.  Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. , 2012, Biomaterials.

[216]  A. Thess,et al.  Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect , 2012, The journal of gene medicine.

[217]  Huan Xu,et al.  Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles. , 2012, Biomaterials.

[218]  F. Bushman,et al.  Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells , 2012, Science Translational Medicine.

[219]  Wei R. Chen,et al.  Antitumor immunologically modified carbon nanotubes for photothermal therapy. , 2012, Biomaterials.

[220]  J. Slansky,et al.  Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. , 2012, Anticancer research.

[221]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[222]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[223]  M. Korbelik,et al.  Photodynamic therapy–generated cancer vaccine elicits acute phase and hormonal response in treated mice , 2012, Cancer Immunology, Immunotherapy.

[224]  J. DeMarco,et al.  Radiation enhances regulatory T cell representation. , 2011, International journal of radiation oncology, biology, physics.

[225]  Ho-Keun Kwon,et al.  Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[226]  K. Margolin,et al.  Cytokines in Cancer Immunotherapy , 2011, Cancers.

[227]  Young Keun Kim,et al.  A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.

[228]  D. Mooney,et al.  The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[229]  Yang Liu,et al.  In vivo delivery of RNAi with lipid-based nanoparticles. , 2011, Annual review of biomedical engineering.

[230]  T. Vermonden,et al.  Functional aliphatic polyesters for biomedical and pharmaceutical applications. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[231]  Wanjun Chen,et al.  Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression , 2011, International journal of biological sciences.

[232]  M. Korbelik.  Cancer vaccines generated by photodynamic therapy , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[233]  L. Harrington,et al.  Cytokines and the inception of CD8 T cell responses. , 2011, Trends in immunology.

[234]  R. Schreiber,et al.  Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.

[235]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[236]  H. Morreau,et al.  Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody , 2011, Clinical Cancer Research.

[237]  Leaf Huang,et al.  Cancer Immunotherapy and Nanomedicine , 2011, Pharmaceutical Research.

[238]  Ralph Weissleder,et al.  High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis , 2010, Circulation.

[239]  R. Tibshirani,et al.  In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[240]  A. El-Kadi,et al.  STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response. , 2010, Molecular pharmaceutics.

[241]  B. Haynes,et al.  Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity , 2010, PloS one.

[242]  Todd N. Erpelding,et al.  Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system , 2010, Biomedical optics express.

[243]  P. Kantoff,et al.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.

[244]  C. van Nostrum,et al.  Hydrophilic Polyester Microspheres: Effect of Molecular Weight and Copolymer Composition on Release of BSA , 2010, Pharmaceutical Research.

[245]  Soong Ho Um,et al.  Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.

[246]  Li Yang,et al.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. , 2010, Trends in immunology.

[247]  Gareth J.S. Jenkins,et al.  Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) , 2010, Nano reviews.

[248]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[249]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[250]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[251]  Saji George,et al.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.

[252]  E. Béraud,et al.  Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles , 2009, International journal of cancer.

[253]  A. Gewirtz,et al.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. , 2009, The Journal of clinical investigation.

[254]  Emmanuelle Canet-Soulas,et al.  Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. , 2009, Radiology.

[255]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[256]  S. Quezada,et al.  Cancer immunotherapy: co‐stimulatory agonists and co‐inhibitory antagonists , 2009, Clinical and experimental immunology.

[257]  Laurence Zitvogel,et al.  Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα , 2009, PloS one.

[258]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[259]  David J. Mooney,et al.  Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.

[260]  D. Irvine,et al.  Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. , 2008, Biomaterials.

[261]  Bernd J. Pichler,et al.  Cell tracking with optical imaging , 2008, European Radiology.

[262]  Oliver Wildner,et al.  Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus , 2008, Vaccine.

[263]  A. Kristal,et al.  Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. , 2008, Carcinogenesis.

[264]  Robert Sinclair,et al.  Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. , 2008, Nano letters.

[265]  S. H. van der Burg,et al.  Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity , 2008, Clinical Cancer Research.

[266]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[267]  E. Repasky,et al.  Enhancement of natural killer (NK) cell cytotoxicity by fever‐range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells , 2007, Journal of leukocyte biology.

[268]  D. Bout,et al.  A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. , 2007, Microbes and infection.

[269]  M. Korbelik,et al.  Photodynamic therapy-generated vaccines: relevance of tumour cell death expression , 2007, British Journal of Cancer.

[270]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[271]  M. Ferrari,et al.  Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2007, Biomedical microdevices.

[272]  V. Diehl,et al.  Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[273]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[274]  J. Fodor.  [Interactions between radiation and hormonal therapy in breast cancer: simultaneous or sequential treatment]. , 2006, Orvosi hetilap.

[275]  Huan Yang,et al.  Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma. , 2005, Archives of otolaryngology--head & neck surgery.

[276]  R. Weissleder,et al.  Nanoparticles for the optical imaging of tumor E-selectin. , 2005, Neoplasia.

[277]  M. Gleave,et al.  Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer , 2005, Clinical Cancer Research.

[278]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[279]  Jung-Ah Cho,et al.  Exosomes: A new delivery system for tumor antigens in cancer immunotherapy , 2005, International journal of cancer.

[280]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[281]  S. Groshen,et al.  Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[282]  N. Kawashima,et al.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[283]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[284]  E. Gilboa,et al.  Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[285]  N. Kawashima,et al.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. , 2004, International journal of radiation oncology, biology, physics.

[286]  L. Zitvogel,et al.  Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells 1 , 2004, The Journal of Immunology.

[287]  Isabelle Raynal,et al.  Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.

[288]  R. Weissleder,et al.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.

[289]  M. Croft.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? , 2003, Nature Reviews Immunology.

[290]  Y. Oh,et al.  Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes. , 2003, Vaccine.

[291]  K. Rai,et al.  Interferon in the treatment of hairy-cell leukemia. , 2003, Best practice & research. Clinical haematology.

[292]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[293]  Barbara W Henderson,et al.  Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.

[294]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[295]  E. Jaffee,et al.  Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. , 2001, Cancer research.

[296]  M. El-Sayed,et al.  Simulation of the Optical Absorption Spectra of Gold Nanorods as a Function of Their Aspect Ratio and the Effect of the Medium Dielectric Constant , 1999 .

[297]  I. Tannock.  Conventional cancer therapy: promise broken or promise delayed? , 1998, The Lancet.

[298]  Chien Ho,et al.  Intracellular labeling of T‐cells with superparamagnetic contrast agents , 1993, Magnetic resonance in medicine.

[299]  J. Krischer,et al.  Interval between symptom onset and diagnosis of pediatric solid tumors. , 1991, The Journal of pediatrics.

[300]  B. Levine,et al.  Engineered T cells: the promise and challenges of cancer immunotherapy , 2016, Nature Reviews Cancer.

[301]  S. Lerouge,et al.  Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies. , 2016, Biomaterials.

[302]  Yifan Ma,et al.  Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. , 2015, Biomaterials.

[303]  A. Salem,et al.  Biodegradable Microparticles Loaded with Doxorubicin and CpG ODN for In Situ Immunization Against Cancer , 2014, The AAPS Journal.

[304]  Min Beom Heo,et al.  Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells. , 2014, Biomaterials.

[305]  Yoonsu Choi,et al.  Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[306]  D. Munn.  Blocking IDO activity to enhance anti-tumor immunity. , 2012, Frontiers in bioscience.

[307]  E. Jaffee,et al.  Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice. , 2010, Cellular immunology.

[308]  G. Parmiani,et al.  Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.

[309]  David Leong,et al.  Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.

[310]  R. Nordquist,et al.  Antitumor immunity induced by laser immunotherapy and its adoptive transfer. , 2001, Cancer research.

[311]  E. Wood,et al.  A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. , 1957, Proceedings of the staff meetings. Mayo Clinic.